NHF Products Licensed for the Treatment of Hemophilia and Selected Disorders of the Coagulation System Guideline Summary

Guideline Central highly recommends you use Google Chrome while using this site.

For optimal experience please use Google Chrome.

Thank you.

By creating an account, I agree to receive occasional communications from Guideline Central. I understand I can opt out of these communications at any time by visiting my account page.

Already have an account? Login

Title

Products Licensed for the Treatment of Hemophilia and Selected Disorders of the Coagulation System

Authoring Organization

Publication Month/Year

August 20, 2023

Document Type

Guideline

Country of Publication

Target Patient Population

Patients with bleeding disorders

Target Provider Population

Healthcare providers caring for patients with bleeding disorders

Inclusion Criteria

Male, Female, Adolescent, Adult, Child, Older adult

Health Care Settings

Ambulatory

Intended Users

Nurse, nurse practitioner, physician, physician assistant

Scope

Management

Diseases/Conditions (MeSH)

D006467 - Hemophilia A, D002836 - Hemophilia B, D014842 - von Willebrand Diseases

Keywords

hemophilia, bleeding disorders, hemophilia a, hemophilia b, coagulation system, licensed products, von Willebrand Disease

Login

Forgot Password

Register